Background: Protection against vaccine-preventable diseases is important in inflammatory bowel disease (IBD) because of increased susceptibility and severity of infection with immunosuppressive therapy. However, immunosuppressive therapy may affect vaccine response. This study aimed to evaluate immu
Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results
β Scribed by M. LAZZERINI; S. MARTELOSSI; F. MARCHETTI; A. SCABAR; F. BRADASCHIA; L. RONFANI; A. VENTURA
- Book ID
- 108604847
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 559 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: Children and adolescents with inflammatory bowel disease (IBD) are more likely to have Crohn's disease (CD) than ulcerative colitis (UC) and their disease tends to be more extensive and severe than in adults. We hypothesized that the prevalence of anemia would therefore be greater in chi
## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticularβcourse juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye